Xspray Pharma Dividends and Buybacks
Dividend criteria checks 0/6
Xspray Pharma does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-16.2%
Buyback Yield
| Total Shareholder Yield | -16.2% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
We Think Xspray Pharma (STO:XSPRAY) Needs To Drive Business Growth Carefully
Feb 25
We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate
May 11We Think Xspray Pharma (STO:XSPRAY) Can Afford To Drive Business Growth
Feb 01We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate
Oct 26We're Not Very Worried About Xspray Pharma's (STO:XSPRAY) Cash Burn Rate
Jun 20We're Hopeful That Xspray Pharma (STO:XSPRAY) Will Use Its Cash Wisely
Mar 19Do Institutions Own Xspray Pharma AB (publ) (STO:XSPRAY) Shares?
Feb 12Here's Why We're Watching Xspray Pharma's (STO:XSPRAY) Cash Burn Situation
Dec 04
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if XSPRAY's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if XSPRAY's dividend payments have been increasing.
Dividend Yield vs Market
| Xspray Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (XSPRAY) | n/a |
| Market Bottom 25% (SE) | 1.6% |
| Market Top 25% (SE) | 4.5% |
| Industry Average (Biotechs) | 1.1% |
| Analyst forecast (XSPRAY) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate XSPRAY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate XSPRAY's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate XSPRAY's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as XSPRAY has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/10 22:30 |
| End of Day Share Price | 2025/02/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Xspray Pharma AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dan Akschuti | Pareto Securities |
| Filip Einarsson | Redeye |